Six-Minute Walk Test in Children With Spastic Cerebral Palsy and Children Developing Typically

Diarmaid Fitzgerald1, Claire Hickey, Eamonn Delahunt

  • 1Gait Laboratory (Dr Fitzgerald, Mr Walsh, and Mr O'Brien), Central Remedial Clinic, Dublin, Ireland; School of Public Health, Physiotherapy and Sports Science (Ms Hickey and Dr Delahunt), University College Dublin, Dublin, Ireland.

Insights

This study established 6-minute walk test (6MWT) reference values for children with spastic cerebral palsy (CP) across GMFCS levels I-III, showing significant differences compared to typically developing (TD) children.

Area of Science:

  • Pediatric Rehabilitation
  • Neurology
  • Biomedical Engineering

Background:

  • Cerebral palsy (CP) is a common neurodevelopmental disorder affecting motor function.
  • The 6-minute walk test (6MWT) is a functional mobility assessment tool.
  • Standardized reference values for the 6MWT in children with CP are needed for clinical and research applications.

Purpose of the Study:

  • To quantify 6-minute walk test (6MWT) distances in children with spastic cerebral palsy (CP) across Gross Motor Function Classification System (GMFCS) levels I to III.
  • To compare 6MWT performance between children with CP and typically developing (TD) children.

Main Methods:

  • 145 children with CP (GMFCS I-III) and 137 TD children completed the 6MWT.
  • Mean 6MWT distances were calculated for each GMFCS level and the TD group.
  • Statistical analysis was performed to compare 6MWT scores.

Main Results:

  • Mean 6MWT distances were: GMFCS I (439.57 ± 49.81 m), GMFCS II (386.74 ± 66.47 m), GMFCS III (305.28 ± 66.95 m), and TD (528.42 ± 67.77 m).
  • Significant differences (P < .001) were observed between all CP GMFCS levels and the TD group.
  • A clear decline in 6MWT distance was noted with increasing GMFCS level in children with CP.

Conclusions:

  • Reference values for 6MWT distance were established for children with spastic CP (GMFCS I-III) and TD children.
  • These values can aid in assessing functional mobility and monitoring progress in pediatric CP populations.
  • The findings highlight the impact of motor impairment severity on walking capacity in children with CP.
Abstract

Related Concept Videos